Plan robustness of simultaneous integrated boost radiotherapy of prostate and lymph nodes for different image-guidance and delivery techniques

被引:20
作者
Thornqvist, Sara [1 ,2 ,3 ]
Bentzen, Lise [3 ]
Petersen, Jorgen B. B. [1 ]
Hysing, Liv B. [4 ]
Muren, Ludvig P. [1 ,2 ,3 ]
机构
[1] Aarhus Univ Hosp, Dept Med Phys, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ, Inst Clin, Aarhus, Denmark
[3] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
[4] Univ Bergen, Dept Med Phys, Haukeland Univ Hosp, Bergen, Norway
关键词
INTENSITY-MODULATED RADIOTHERAPY; DOSE CONFORMAL RADIOTHERAPY; CANCER PATIENTS; THERAPY; TRIAL; RISK; ESCALATION; NEOADJUVANT; VARIABILITY; IRRADIATION;
D O I
10.3109/0284186X.2011.590522
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose. Uncorrelated motion of targets and large deformations of organs at risk represent challenges for image-guidance in simultaneous integrated boost (SIB) radiotherapy (RT) of pelvic tumour sites. This study aims to evaluate the robustness towards geometrical uncertainties in prostate cancer using two image-guided RT (IGRT) set-up strategies for two SIB delivery methods. Secondly, we evaluate the ability of geometrical parameters to predict when the applied margins are insufficient, resulting in target underdosage (TUD). Material and methods. The study included nine patients with eight to nine repeat computed tomography (CT)-scans evenly distributed throughout their treatment course. The prostate target (CTV-p) and the lymph node target including seminal vesicles (CTV-ln/sv) were delineated in all scans. SIB treatment plans for intensity-modulated RT and volumetric modulated arc therapy were generated on the planning CT and transferred to the repeat CTs for dose re-calculation using registration based on either anatomy or intra-prostatic fiducial markers. Receiving operator characteristic analysis was used to deduce the ability of the parameters to predict TUD. Results. The dosimetric differences between the two positioning strategies were small for all parameters evaluated and significant only for the dose to rectum. Anatomy based registration resulted in inferior target coverage with a larger number of TUDs, mostly seen in the seminal vesicles. For both targets the highest sensitivity and specificity of predicting TUD was seen for the relative volume and the lowest was found for the displacement vector. Conclusions. Positioning based on fiducials gave the best trade-off between coverage of the targets although resulting in the highest dose to rectum. Target underdosage occurred mostly in the seminal vesicles. For both targets, the best parameter to predict TUD was the relative volume.
引用
收藏
页码:926 / 934
页数:9
相关论文
共 36 条
  • [1] Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy
    Ashman, JB
    Zelefsky, MJ
    Hunt, MS
    Leibel, SA
    Fuks, Z
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (03): : 765 - 771
  • [2] CLINICAL APPLICATION OF HIGH-DOSE, IMAGE-GUIDED INTENSITY-MODULATED RADIOTHERAPY IN HIGH-RISK PROSTATE CANCER
    Bayley, Andrew
    Rosewall, Tara
    Craig, Tim
    Bristow, Rob
    Chung, Peter
    Gospodarowicz, Mary
    Menard, Cynthia
    Milosevic, Michael
    Warde, Padraig
    Catton, Charles
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (02): : 477 - 483
  • [3] Intrafractional prostate motion during online image guided intensity-modulated radiotherapy for prostate cancer
    Budiharto, Tom
    Slagmolen, Pieter
    Haustermans, Karin
    Maes, Frederik
    Junius, Sara
    Verstraete, Jan
    Oyen, Raymond
    Hermans, Jeroen
    Van den Heuvel, Frank
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 98 (02) : 181 - 186
  • [4] Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial
    Dearnaley, David P.
    Sydes, Matthew R.
    Graham, John D.
    Aird, Edwin G.
    Bottomley, David
    Cowan, Richard A.
    Huddart, Robert A.
    Jose, Chakiath C.
    Matthews, John H. L.
    Millar, Jeremy
    Moore, A. Rollo
    Morgan, Rachel C.
    Russell, J. Martin
    Scrase, Christopher D.
    Stephens, Richard J.
    Syndikus, Isabel
    Parmar, Mahesh K. B.
    [J]. LANCET ONCOLOGY, 2007, 8 (06) : 475 - 487
  • [5] MEASURES OF THE AMOUNT OF ECOLOGIC ASSOCIATION BETWEEN SPECIES
    DICE, LR
    [J]. ECOLOGY, 1945, 26 (03) : 297 - 302
  • [6] Receiver operating characteristic analysis: A primer
    Eng, J
    [J]. ACADEMIC RADIOLOGY, 2005, 12 (07) : 909 - 916
  • [7] Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning
    Fiorino, C
    Reni, M
    Bolognesi, A
    Cattaneo, GM
    Calandrino, R
    [J]. RADIOTHERAPY AND ONCOLOGY, 1998, 47 (03) : 285 - 292
  • [8] 70 Gy or more: which dose for which prostate cancer?
    Ganswindt, U
    Paulsen, F
    Anastasiadis, AG
    Stenzl, A
    Bamberg, M
    Belka, C
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (07) : 407 - 419
  • [9] Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery
    Ghilezan, M
    Yan, D
    Liang, J
    Jaffray, D
    Wong, J
    Martinez, A
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (05): : 1602 - 1610
  • [10] Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy
    Karlsdottir, Asa
    Muren, Ludvig Paul
    Wentzel-Larsen, Tore
    Johannessen, Dag C.
    Haukaas, Svein Andreas
    Halvorsen, Ole Johan
    Dahl, Olav
    [J]. ACTA ONCOLOGICA, 2009, 48 (06) : 874 - 881